BIO-Europe 2026

Meet Henrik Schmidt at BIO-Europe 2026

We will be attending BIO-Europe 2026 taking place in Cologne, Germany from November 9-11, 2026. Henrik Schmidt, VP Commercial Europe & APAC, will be representing Myllia as he leads strategic partnerships and R&D collaborations across pharmaceutical and biotechnology organizations.

Is your R&D organization looking to unlock deeper biological insights through advanced functional genomics technologies such as pooled CRISPR screening, CROP-seq/Perturb-seq, and single-cell multi-omics in disease-relevant primary human cell models? These approaches move beyond traditional target discovery methods by generating high-resolution datasets that directly link genetic perturbations to cellular phenotypes, enabling more informed target identification and validation.

At BIO-Europe, we’ll be happy to discuss:

– Strategic R&D partnerships and target discovery
– CRISPR screening and single-cell genomics in primary human cell models
– Functional genomics datasets for AI-driven drug discovery
– Licensing, co-development, and long-term collaboration opportunities

Whether you are exploring new therapeutic targets, evaluating disease-relevant human cell models, or seeking differentiated datasets to power AI and machine learning initiatives, Henrik would welcome the opportunity to connect and discuss how Myllia can support your research and business objectives.